Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2023.2201371
Abstract: ABSTRACT Introduction Cisplatin-based chemotherapy is currently considered the gold-standard treatment for metastatic urothelial carcinoma (mUC). Nevertheless, most mUC patients develop resistance to chemotherapy. Immune checkpoint inhibitors (ICI) have emerged as a therapeutic option for mUC.… read more here.
Keywords: utility checkpoint; checkpoint inhibitors; clinical utility; chemotherapy ... See more keywords